Probiotic product enhances susceptibility of mice to cryptosporidiosis

Applied and Environmental Microbiology

Volumn 84, Issue 21, 2018, Pages

  Oliveira, Bruno C M ^a,b   Widmer, Giovanni ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cryptosporidiosis; Cryptosporidium; Fecal microbiota; Gut microbiota; Probiotics

Indexed keywords

POTABLE WATER;

CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; FECAL MICROBIOTA; GUT MICROBIOTA; PROBIOTICS;

MAMMALS;

ABUNDANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL DISEASE; BACTERIUM; DIGESTIVE SYSTEM; DISEASE SEVERITY; DISEASE TREATMENT; DRINKING WATER; DRUG; INFECTIOUS DISEASE; MICROBIAL ACTIVITY; PARASITIC DISEASE; PATHOGEN; PROBIOTICS;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; MUS;

PROBIOTIC AGENT;

ANIMAL; BACTERIUM; CLASSIFICATION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE PREDISPOSITION; DRUG EFFECT; FECES; FEMALE; GENETICS; HUMAN; INTESTINE; INTESTINE FLORA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; BACTERIA; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE SUSCEPTIBILITY; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; MICE; PROBIOTICS; TREATMENT OUTCOME;

EID: 85055071542     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01408-18     Document Type: Article

References (62)

1. Rochelle PA, Di Giovanni GD. 2014. Cryptosporidium oocysts in drinking water and recreational water, p 489-513. In Caccìo SM, Widmer G (ed), Cryptosporidium: parasite and disease. Springer, New York, NY
2. Cacciò SM, Putignani L. 2014. Epidemiology of human cryptosporidiosis, p 43-79. In Caccìo SM, Widmer G (ed), Cryptosporidium: parasite and disease. Springer, New York, NY
3. Mor SM, Tumwine JK, Ndeezi G, Srinivasan MG, Kaddu-Mulindwa DH, Tzipori S, Griffiths JK. 2010. Respiratory cryptosporidiosis in HIVseronegative children in Uganda: potential for respiratory transmission. Clin Infect Dis 50:1366-1372. https://doi.org/10.1086/652140
4. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. https:// doi.org/10.1016/S0140-6736(13)60844-2
5. Ras R, Huynh K, Desoky E, Badawy A, Widmer G. 2015. Perturbation of the intestinal microbiota of mice infected with Cryptosporidium parvum. Int J Parasitol 45:567-573. https://doi.org/10.1016/j.ijpara.2015.03.005
6. Harp JA, Chen W, Harmsen AG. 1992. Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: the importance of intestinal microflora. Infect Immun 60:3509-3512
7. Harp JA. 2003. Cryptosporidium and host resistance: historical perspective and some novel approaches. Anim Health Res Rev 4:53-62. https:// doi.org/10.1079/AHRR200352
8. Lacroix-Lamande S, Guesdon W, Drouet F, Potiron L, Lantier L, Laurent F. 2014. The gut flora is required for the control of intestinal infection by poly(I:C) administration in neonates. Gut Microbes 5:533-540. https:// doi.org/10.4161/gmic.29154
9. Lantier L, Drouet F, Guesdon W, Mancassola R, Metton C, Lo-Man R, Werts C, Laurent F, Lacroix-Lamande S. 2014. Poly(I:C)-induced protection of neonatal mice against intestinal Cryptosporidium parvum infection requires an additional TLR5 signal provided by the gut flora. J Infect Dis 209:457-467. https://doi.org/10.1093/infdis/jit432
10. Gorla SK, McNair NN, Yang G, Gao S, Hu M, Jala VR, Haribabu B, Striepen B, Cuny GD, Mead JR, Hedstrom L. 2014. Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis. Antimicrob Agents Chemother 58:1603-1614. https://doi.org/10.1128/AAC.02075-13
11. Preidis GA, Saulnier DM, Blutt SE, Mistretta TA, Riehle KP, Major AM, Venable SF, Finegold MJ, Petrosino JF, Conner ME, Versalovic J. 2012. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J 26:1960-1969. https://doi.org/10 .1096/fj.10-177980
12. Rodrigues DM, Sousa AJ, Johnson-Henry KC, Sherman PM, Gareau MG. 2012. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis 206:99-109. https://doi.org/10.1093/infdis/jis177
13. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8:e1002995. https://doi.org/10.1371/journal.ppat.1002995
14. Kondepudi KK, Ambalam P, Karagin PH, Nilsson I, Wadstrom T, Ljungh A. 2014. A novel multi-strain probiotic and synbiotic supplement for prevention of Clostridium difficile infection in a murine model. Microbiol Immunol 58:552-558. https://doi.org/10.1111/1348-0421.12184
15. Colenutt C, Cutting SM. 2014. Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model. FEMS Microbiol Lett 358:154-161. https://doi.org/10.1111/1574-6968.12468
16. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MR, Jenq RR, Taur Y, Sander C, Cross JR, Toussaint NC, Xavier JB, Pamer EG. 2015. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:205-208. https://doi.org/ 10.1038/nature13828
17. Liu Z, Liu W, Ran C, Hu J, Zhou Z. 2016. Abrupt suspension of probiotics administration may increase host pathogen susceptibility by inducing gut dysbiosis. Sci Rep 6:23214. https://doi.org/10.1038/srep23214
18. Spinler JK, Brown A, Ross CL, Boonma P, Conner ME, Savidge TC. 2016. Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease. Anaerobe 40:54-57. https://doi.org/10.1016/j .anaerobe.2016.05.008
19. Schlundt J. 2006. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Food and Agriculture Organization of the United Nations, World Health Organization, Rome, Italy. http://www.fao.org/3/a-a0512e.pdf
20. Koretz RL. 2018. Probiotics in gastroenterology: how pro is the evidence in adults? Am J Gastroenterol 113:1125-1136. https://doi.org/10.1038/ s41395-018-0138-0
21. Zhu W, Winter MG, Byndloss MX, Spiga L, Duerkop BA, Hughes ER, Buttner L, de Lima Romao E, Behrendt CL, Lopez CA, Sifuentes-Dominguez L, Huff-Hardy K, Wilson RP, Gillis CC, Tukel C, Koh AY, Burstein E, Hooper LV, Baumler AJ, Winter SE. 2018. Precision editing of the gut microbiota ameliorates colitis. Nature 553:208-211. https://doi .org/10.1038/nature25172
22. Kao MS, Huang S, Chang WL, Hsieh MF, Huang CJ, Gallo RL, Huang CM. 2017. Microbiome precision editing: using PEG as a selective fermentation initiator against methicillin-resistant Staphylococcus aureus. Biotechnol J 12. https://doi.org/10.1002/biot.201600399
23. Theriot CM. 2018. Beyond structure: defining the function of the gut using omic approaches for rational design of personalized therapeutics. mSystems 3:e00173-17. https://doi.org/10.1128/mSystems.00173-17
24. Lozupone C, Hamady M, Knight R. 2006. UniFrac: an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 7:371-385. https://doi.org/10.1186/1471-2105-7-371
25. Clarke KR. 1993. Non-parametric multivariate analyses of changes in community structure. Aust J Ecol 18:117-143. https://doi.org/10.1111/j .1442-9993.1993.tb00438.x
26. Keeney KM, Yurist-Doutsch S, Arrieta MC, Finlay BB. 2014. Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol 68:217-235. https://doi.org/10.1146/annurev-micro-091313-103456
27. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. 2011. Metagenomic biomarker discovery and explanation. Genome Biol 12:R60. https://doi.org/10.1186/gb-2011-12-6-r60
28. ter Braak CJF, Smilauer P. 2002. CANOCO reference manual and CanoDraw for Windows user's guide: software for canonical community ordination (version 4.5). Microcomputer Power, Ithaca, NY
29. David LA, Weil A, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ. 2015. Gut microbial succession follows acute secretory diarrhea in humans. mBio 6:e00381-15. https://doi .org/10.1128/mBio.00381-15
30. Monira S, Nakamura S, Gotoh K, Izutsu K, Watanabe H, Alam NH, Nakaya T, Horii T, Ali SI, Iida T, Alam M. 2013. Metagenomic profile of gut microbiota in children during cholera and recovery. Gut Pathog 5:1. https://doi.org/10.1186/1757-4749-5-1
31. Pop M, Walker AW, Paulson J, Lindsay B, Antonio M, Hossain MA, Oundo J, Tamboura B, Mai V, Astrovskaya I, Corrada Bravo H, Rance R, Stares M, Levine MM, Panchalingam S, Kotloff K, Ikumapayi UN, Ebruke C, Adeyemi M, Ahmed D, Ahmed F, Alam MT, Amin R, Siddiqui S, Ochieng JB, Ouma E, Juma J, Mailu E, Omore R, Morris JG, Breiman RF, Saha D, Parkhill J, Nataro JP, Stine OC. 2014. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol 15:R76. https://doi.org/10.1186/gb-2014-15-6-r76
32. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C. 2013. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31: 814-821. https://doi.org/10.1038/nbt.2676
33. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. 2016. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med 8:52. https://doi.org/10.1186/s13073-016-0300-5
34. Faith JJ, Ahern PP, Ridaura VK, Cheng J, Gordon JI. 2014. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med 6:220ra11. https://doi.org/10.1126/ scitranslmed.3008051
35. Winter SE, Lopez CA, Baumler AJ. 2013. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep 14:319-327. https://doi.org/10.1038/embor.2013.27
36. Becker-Dreps S, Allali I, Monteagudo A, Vilchez S, Hudgens MG, Rogawski ET, Carroll IM, Zambrana LE, Espinoza F, Azcarate-Peril MA. 2015. Gut microbiome composition in young Nicaraguan children during diarrhea episodes and recovery. Am J Trop Med Hyg 93:1187-1193. https://doi .org/10.4269/ajtmh.15-0322
37. Hsiao A, Ahmed AM, Subramanian S, Griffin NW, Drewry LL, Petri WA, Jr, Haque R, Ahmed T, Gordon JI. 2014. Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature 515:423-426. https://doi.org/10.1038/nature13738
38. Barash NR, Maloney JG, Singer SM, Dawson SC. 2017. Giardia alters commensal microbial diversity throughout the murine gut. Infect Immun 85:e00948-16. https://doi.org/10.1128/IAI.00948-16
39. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. 2012. IBD: what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 9:219-230. https:// doi.org/10.1038/nrgastro.2012.14
40. Munyaka PM, Rabbi MF, Khafipour E, Ghia JE. 2016. Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice. J Basic Microbiol 56:986-998. https://doi.org/10.1002/jobm.201500726
41. Gillis CC, Hughes ER, Spiga L, Winter MG, Zhu W, Furtado de Carvalho T, Chanin RB, Behrendt CL, Hooper LV, Santos RL, Winter SE. 2018. Dysbiosis-associated change in host metabolism generates lactate to support Salmonella growth. Cell Host Microbe 23:54-64.e6. https://doi .org/10.1016/j.chom.2017.11.006
42. Manor O, Levy R, Pope CE, Hayden HS, Brittnacher MJ, Carr R, Radey MC, Hager KR, Heltshe SL, Ramsey BW, Miller SI, Hoffman LR, Borenstein E. 2016. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis. Sci Rep 6:22493. https://doi.org/10.1038/srep22493
43. Espey MG. 2013. Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota. Free Radic Biol Med 55:130-140. https://doi.org/10.1016/j.freeradbiomed.2012.10.554
44. Tzipori S, Rand W, Griffiths J, Widmer G, Crabb J. 1994. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin Diagn Lab Immunol 1:450-463
45. Argenzio RA, Liacos JA, Levy ML, Meuten DJ, Lecce JG, Powell DW. 1990. Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology 98:1129-1140. https://doi.org/10.1016/0016-5085(90)90325-U
46. Vitovec J, Koudela B. 1992. Pathogenesis of intestinal cryptosporidiosis in conventional and gnotobiotic piglets. Vet Parasitol 43:25-36. https:// doi.org/10.1016/0304-4017(92)90045-B
47. Liu J, Bolick DT, Kolling GL, Fu Z, Guerrant RL. 2016. Protein malnutrition impairs intestinal epithelial cell turnover, a potential mechanism of increased cryptosporidiosis in a murine model. Infect Immun 84: 3542-3549. https://doi.org/10.1128/IAI.00705-16
48. Current WL, Haynes TB. 1984. Complete development of Cryptosporidium in cell culture. Science 224:603-605. https://doi.org/10.1126/ science.6710159
49. Weyl-Feinstein S, Markovics A, Eitam H, Orlov A, Yishay M, Agmon R, Miron J, Izhaki I, Shabtay A. 2014. Short communication: effect of pomegranate-residue supplement on Cryptosporidium parvum oocyst shedding in neonatal calves. J Dairy Sci 97:5800-5805. https://doi.org/ 10.3168/jds.2013-7136
50. Jansson JK, Baker ES. 2016. A multi-omic future for microbiome studies. Nat Microbiol 1:16049. https://doi.org/10.1038/nmicrobiol.2016.49
51. Okhuysen PC, Rich SM, Chappell CL, Grimes KA, Widmer G, Feng XC, Tzipori S. 2002. Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-γ knockout mice. J Infect Dis 185:1320-1325. https://doi.org/10.1086/340132
52. Widmer G, Lee Y, Hunt P, Martinelli A, Tolkoff M, Bodi K. 2012. Comparative genome analysis of two Cryptosporidium parvum isolates with different host range. Infect Genet Evol 12:1213-1221. https://doi.org/10 .1016/j.meegid.2012.03.027
53. Mallon ME, MacLeod A, Wastling JM, Smith H, Tait A. 2003. Multilocus genotyping of Cryptosporidium parvum type 2: population genetics and sub-structuring. Infect Genet Evol 3:207-218. https://doi.org/10.1016/ S1567-1348(03)00089-3
54. Widmer G, Feng X, Tanriverdi S. 2004. Genotyping of Cryptosporidium parvum with microsatellite markers. Methods Mol Biol 268:177-187
55. Yang S, Healey MC. 1993. The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with Cryptosporidium parvum. J Parasitol 79:626-630. https://doi.org/10 .2307/3283395
56. Peakall R, Smouse PE. 2012. GenAlEx 6.5: genetic analysis in Excel: population genetic software for teaching and research: an update. Bioinformatics 28:2537-2539. https://doi.org/10.1093/bioinformatics/ bts460
57. Stroup SE, Roy S, McHele J, Maro V, Ntabaguzi S, Siddique A, Kang G, Guerrant RL, Kirkpatrick BD, Fayer R, Herbein J, Ward H, Haque R, Houpt ER. 2006. Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes. J Med Microbiol 55:1217-1222. https:// doi.org/10.1099/jmm.0.46678-0
58. Baker GC, Smith JJ, Cowan DA. 2003. Review and re-analysis of domainspecific 16S primers. J Microbiol Methods 55:541-555. https://doi.org/ 10.1016/j.mimet.2003.08.009
59. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: opensource, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537-7541. https://doi.org/10.1128/AEM.01541-09
60. McMurdie PJ, Holmes S. 2014. Waste not, want not: why rarefying microbiome data is inadmissible. PLoS Comput Biol 10:e1003531. https://doi.org/10.1371/journal.pcbi.1003531
61. Huse SM, Welch DM, Morrison HG, Sogin ML. 2010. Ironing out the wrinkles in the rare biosphere through improved OTU clustering. Environ Microbiol 12:1889-1898. https://doi.org/10.1111/j.1462-2920.2010 .02193.x
62. Westcott SL, Schloss PD. 2017. OptiClust, an improved method for assigning amplicon-based sequence data to operational taxonomic units. mSphere 2:e00073-17. https://doi.org/10.1128/mSphereDirect .00073-17